Stany Zjednoczone - angielski - NLM (National Library of Medicine)

allergan, inc. - eluxadoline (unii: 45tpj4mbq1) (eluxadoline - unii:45tpj4mbq1) - eluxadoline 75 mg - viberzi  is indicated in adults for the treatment of irritable bowel syndrome with diarrhea (ibs-d). viberzi is contraindicated in patients: - without a gallbladder. these patients are at increased risk of developing serious adverse reactions of pancreatitis and/or sphincter of oddi spasm [see warnings and precautions ( 5.1, 5.2)] - with known or suspected biliary duct obstruction; or sphincter of oddi disease or dysfunction. these patients are at increased risk for sphincter of oddi spasm [see warnings and precautions   ( 5.1)]. - with alcoholism, alcohol abuse or alcohol addiction, or in patients who drink more than 3 alcoholic beverages per day. these patients are at increased risk for acute pancreatitis [see warnings and precautions ( 5.1)] . - with a history of pancreatitis; or structural diseases of the pancreas, including known or suspected pancreatic duct obstruction. these patients are at increased risk for acute pancreatitis [see warnings and precautions ( 5.1)] . - with a known hypersensitivity r

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

rising pharmaceuticals inc. - bethanechol chloride (unii: h4qbz2lo84) (bethanechol - unii:004f72p8f4) - bethanechol chloride 5 mg - bethanechol chloride is indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. hypersensitivity to bethanechol chloride tablets, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy and parkinsonism. bethanechol chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

novartis ophthalmics - carbachol (unii: 8y164v895y) (carbachol - unii:8y164v895y) - injection, solution - 0.1 mg in 1 ml - intraocular use for obtaining miosis during surgery. in addition, carbastat® (carbachol intraocular solution usp) reduces the intensity of intraocular pressure elevation in the first 24 hours after cataract surgery. should not be used in those persons showing hypersensitivity to any of the components of this preparation.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

teva women's health, inc. - bethanechol chloride (unii: h4qbz2lo84) (bethanechol - unii:004f72p8f4) - bethanechol chloride 5 mg - bethanechol chloride tablets usp are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. hypersensitivity to bethanechol chloride, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy and parkinsonism. bethanechol chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - bethanechol chloride (unii: h4qbz2lo84) (bethanechol - unii:004f72p8f4) - bethanechol chloride 5 mg - bethanechol chloride tablets usp are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. hypersensitivity to bethanechol chloride, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy and parkinsonism. bethanechol chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

upsher-smith laboratories, llc - bethanechol chloride (unii: h4qbz2lo84) (bethanechol - unii:004f72p8f4) - bethanechol chloride 5 mg - bethanechol chloride tablets are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. hypersensitivity to bethanechol chloride tablets, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy and parkinsonism. bethanechol chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

novartis animal health us, inc. - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - milbemycin oxime 2.3 mg

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

alcon laboratories, inc. - carbachol (unii: 8y164v895y) (carbamoylcholine - unii:54z8m50d6q) - carbachol 0.1 mg in 1 ml - intraocular use for obtaining miosis during surgery. in addition, miostat* (carbachol intraocular solution, usp) 0.01% reduces the intensity of iop elevation in the first 24 hours after cataract surgery. should not be used in those persons showing hypersensitivity to any of the components of this preparation. safety and efficacy in pediatric patients have not been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - carbachol, quantity: 100 microgram/ml - injection, solution - excipient ingredients: sodium citrate dihydrate; potassium chloride; hydrochloric acid; sodium acetate; sodium hydroxide; calcium chloride dihydrate; sodium chloride; magnesium chloride hexahydrate; water for injections - intraocular use for miosis during surgery.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - bethanechol chloride, quantity: 10 mg - tablet, uncoated - excipient ingredients: erythrosine; magnesium stearate; wheat starch; amaranth; lactose monohydrate; acacia; hydrogenated vegetable oil - acute post-operative and postpartum non-obstructive urinary retension, and neurogenic atony of the urinary bladder with retension. bethanechol has no clinically significant nicotinic stimulant activity.